2018
DOI: 10.1007/s11626-018-0276-0
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac differentiation at an initial low density of human-induced pluripotent stem cells

Abstract: A high density of human-induced pluripotent stem cells (hiPSCs) improves the efficiency of cardiac differentiation, suggesting the existence of indispensable cell-cell interaction signals. The complexity of interactions among cells at high density hinders the understanding of the roles of cell signals. In this study, we determined the minimum cell density that can initiate differentiation to facilitate cell-cell interaction studies. First, we co-induced cardiac differentiation in the presence of the glycogen s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(15 citation statements)
references
References 32 publications
0
15
0
Order By: Relevance
“…The experimental manipulation of stem/progenitor cells has led to continuous improvements in cell viability, differentiation efficiency, and functional activity (Laco et al, 2018;Le et al, 2018;Biermann et al, 2019;Cai et al, 2019;Leitolis et al, 2019;Valls-Margarit et al, 2019;Yang et al, 2019;Zhu et al, 2020). Contemporary protocols for differentiating human induced-pluripotent stem cells (hiPSCs) into cardiomyocytes (hiPSC-CMs) are often based on the GiWi method, which uses small-molecule inhibitors of glycogen synthase kinase (GSK) and tankyrase to alternately activate and then suppress the Wnt signaling pathway (Mazzola and Pasquale, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…The experimental manipulation of stem/progenitor cells has led to continuous improvements in cell viability, differentiation efficiency, and functional activity (Laco et al, 2018;Le et al, 2018;Biermann et al, 2019;Cai et al, 2019;Leitolis et al, 2019;Valls-Margarit et al, 2019;Yang et al, 2019;Zhu et al, 2020). Contemporary protocols for differentiating human induced-pluripotent stem cells (hiPSCs) into cardiomyocytes (hiPSC-CMs) are often based on the GiWi method, which uses small-molecule inhibitors of glycogen synthase kinase (GSK) and tankyrase to alternately activate and then suppress the Wnt signaling pathway (Mazzola and Pasquale, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…The KOSM4 hiPSC line, established using a SeVdp-iPS vector 14 , 15 , was used for all experiments unless otherwise stated. The cells were plated on a fibronectin-coated dish with serum-free medium and were maintained in an ESF9a-based medium with daily medium changes 14 .…”
Section: Methodsmentioning
confidence: 99%
“…In this study, we tested our hypothesis that auto/paracrine factors and Wnt-modulating signals are the primary effects of high cell density during cardiomyocyte differentiation from hiPSCs. To clarify the effects of cell density, we have previously established a method to induce cardiomyocytes from hiPSCs at an initial low cell density (1% confluence) 14 . However, low differentiation efficiency was obtained with only 4% cardiac troponin T (cTnT) expression.…”
Section: Introductionmentioning
confidence: 99%
“…Once the differentiation procedure is optimized, it enables the control of differentiation process without relying on cell density. That leads higher productivity even differentiation induction is commenced at 1% cell confluency [88].…”
Section: Application Of Human Pluripotent Stem Cells For Cardiomyomentioning
confidence: 99%
“…Regarding the homogeneity in cell population of the 2D monolayer culture, several groups noticed that more beating cells can be obtained in the peripheral side of the culture dishes, so-called the rim effect [88,96,97]. Laco et al demonstrated that the peripheral cells tend to have higher level of cell proliferation, thus promoting cell contraction earlier and stronger than the center cells [98].…”
Section: Application Of Human Pluripotent Stem Cells For Cardiomyomentioning
confidence: 99%